Navigation

 Industry News 

Topics

The Supreme Court, Medication Abortion, and the FDA
INDUSTRY Nicholas Gatorano INDUSTRY Nicholas Gatorano

The Supreme Court, Medication Abortion, and the FDA

The Supreme Court is poised to make crucial decisions regarding medication abortion and the authority of the Food and Drug Administration (FDA). These decisions have significant implications for women's health, regulatory power, and the availability of abortion services across the United States.

Read More
Medicaid Redeterminations and Their Impact on Insurers
INDUSTRY Nicholas Gatorano INDUSTRY Nicholas Gatorano

Medicaid Redeterminations and Their Impact on Insurers

As the process of Medicaid redeterminations begins, major players in the health insurance market are experiencing significant impacts. Companies like UnitedHealth, Centene, and others are adapting to these changes, which affect millions of Americans and the stability of the insurance market.

Read More
CMS Urged to Address Health Insurance Twisting
INDUSTRY Nicholas Gatorano INDUSTRY Nicholas Gatorano

CMS Urged to Address Health Insurance Twisting

Consumer advocates and health experts are urging the Centers for Medicare & Medicaid Services (CMS) to take stronger action against "twisting" practices in the health insurance industry. Twisting occurs when insurers persuade policyholders to switch policies unnecessarily, often leading to higher costs and reduced coverage for consumers.

Read More
IDPH Announces Plan for Maternal Health
INDUSTRY Nicholas Gatorano INDUSTRY Nicholas Gatorano

IDPH Announces Plan for Maternal Health

The Illinois Department of Public Health (IDPH) has unveiled a comprehensive $1.7 billion spending plan for the upcoming fiscal year, with a significant focus on improving maternal health. This initiative, spearheaded by IDPH Director Dr. Sameer Vohra, aims to address and reduce the disparities in maternal health outcomes across the state.

Read More
E-Prescribing Mandate in Illinois: What You Need to Know
INDUSTRY Nicholas Gatorano INDUSTRY Nicholas Gatorano

E-Prescribing Mandate in Illinois: What You Need to Know

Starting January 1, 2024, Illinois will require all healthcare providers who prescribe controlled substances to submit prescriptions electronically. This new legislation, known as the E-Prescribing Mandate, aims to enhance patient safety, reduce prescription errors, and combat prescription drug abuse by ensuring more secure and accurate prescribing practices.

Read More
Utilization Management Head to Governor
INDUSTRY Nicholas Gatorano INDUSTRY Nicholas Gatorano

Utilization Management Head to Governor

Recent changes to health insurance regulations in Illinois aim to address utilization management practices, streamlining processes for patients and improving access to necessary treatments. The new legislation, which has been passed by the Illinois General Assembly, is now awaiting the governor's signature. These changes promise to enhance the way healthcare is managed and accessed in the state.

Read More
Medicaid Unwinding Post-COVID
INDUSTRY Nicholas Gatorano INDUSTRY Nicholas Gatorano

Medicaid Unwinding Post-COVID

Explore the critical findings from the KFF Survey on Medicaid Unwinding after COVID-19, detailing the challenges of over 20 million disenrolled and the ongoing impact on health and coverage. Learn about the difficulties faced during renewal, the disparity between states, and the urgent call for policy improvements.

Read More
Novo Nordisk’s Sudden Discontinuation of Essential Insulin Brand
INDUSTRY Nicholas Gatorano INDUSTRY Nicholas Gatorano

Novo Nordisk’s Sudden Discontinuation of Essential Insulin Brand

In a recent move that sparked significant concern, Novo Nordisk, a major pharmaceutical company, announced the discontinuation of Levemir, a widely used long-acting insulin, prompting urgent inquiries from U.S. Senators. Senators Jeanne Shaheen (D-NH), Raphael Warnock (D-GA), and Elizabeth Warren (D-MA) have voiced their alarm and are demanding explanations from the company, citing concerns over patient access to affordable insulin alternatives.

Read More